BACKGROUND: The role of human leukocyte antigen (HLA) genes in mediating adaptive immune responses to smallpox vaccine remains unknown. METHODS: We determined genotypes for a group of individuals (n = 1071) who received a single dose of smallpox vaccine (Dryvax, Wyeth Laboratories) and examined associations between HLA alleles and 15 immune outcomes to smallpox vaccine on a per-locus and a per-allele level. RESULTS: We found significant associations between the HLA-B and HLA - DQB1 loci and vaccinia-induced antibodies (P = .04 for each locus), with the HLA-B*1302 (P = .036), B*3802 (P = .011), DQB1*0302 (P = .015), and DQB1*0604 (P = .017) alleles being associated with higher levels. Significant global associations were identified between vaccinia-specific interferon (IFN)-γ and DQA1 (P = .003), interleukin (IL)-1β and HLA-B (P = .004), tumor necrosis factor (TNF)-α and HLA-B (P = .006), and IL-6 and HLA-B locus (P = .016) for secreted cytokines, as well as between CD8α(+) IFN-γ Elispot responses and DQB1 (P = .027). Subjects carrying B*3906 (P = .006) and B*5701 (P < .001) secreted higher levels of IL-1β than did subjects who did not carry these alleles. Subjects carrying the B*5301 (P = .047) and B*5601 (P = .008) alleles secreted less IL-1β, compared with subjects who did not carry these alleles. The B*3502 (P = .009), B*5601 (P = .004), and B*5701 (P < .001) alleles were significantly associated with variations in TNF-α secretion. CONCLUSIONS: These data suggest that variations in antibody and cellular IFN-γ, IL-1β, TNF-α, and IL-6 immune responses after receipt of smallpox vaccine are genetically controlled by HLA genes or genes in close linkage disequilibrium to these alleles.
BACKGROUND: The role of human leukocyte antigen (HLA) genes in mediating adaptive immune responses to smallpox vaccine remains unknown. METHODS: We determined genotypes for a group of individuals (n = 1071) who received a single dose of smallpox vaccine (Dryvax, Wyeth Laboratories) and examined associations between HLA alleles and 15 immune outcomes to smallpox vaccine on a per-locus and a per-allele level. RESULTS: We found significant associations between the HLA-B and HLA - DQB1 loci and vaccinia-induced antibodies (P = .04 for each locus), with the HLA-B*1302 (P = .036), B*3802 (P = .011), DQB1*0302 (P = .015), and DQB1*0604 (P = .017) alleles being associated with higher levels. Significant global associations were identified between vaccinia-specific interferon (IFN)-γ and DQA1 (P = .003), interleukin (IL)-1β and HLA-B (P = .004), tumor necrosis factor (TNF)-α and HLA-B (P = .006), and IL-6 and HLA-B locus (P = .016) for secreted cytokines, as well as between CD8α(+) IFN-γ Elispot responses and DQB1 (P = .027). Subjects carrying B*3906 (P = .006) and B*5701 (P < .001) secreted higher levels of IL-1β than did subjects who did not carry these alleles. Subjects carrying the B*5301 (P = .047) and B*5601 (P = .008) alleles secreted less IL-1β, compared with subjects who did not carry these alleles. The B*3502 (P = .009), B*5601 (P = .004), and B*5701 (P < .001) alleles were significantly associated with variations in TNF-α secretion. CONCLUSIONS: These data suggest that variations in antibody and cellular IFN-γ, IL-1β, TNF-α, and IL-6 immune responses after receipt of smallpox vaccine are genetically controlled by HLA genes or genes in close linkage disequilibrium to these alleles.
Authors: Inna G Ovsyannikova; Robert M Jacobson; Jenna E Ryan; Neelam Dhiman; Robert A Vierkant; Gregory A Poland Journal: Clin Vaccine Immunol Date: 2007-01-10
Authors: Inna G Ovsyannikova; V Shane Pankratz; Robert A Vierkant; Robert M Jacobson; Gregory A Poland Journal: J Infect Dis Date: 2006-01-27 Impact factor: 5.226
Authors: Samuel L Stanley; Sharon E Frey; Patricia Taillon-Miller; Jianhua Guo; Raymond D Miller; Daniel C Koboldt; Michael Elashoff; Ryan Christensen; Nancy L Saccone; Robert B Belshe Journal: J Infect Dis Date: 2007-06-04 Impact factor: 5.226
Authors: Inna G Ovsyannikova; Robert M Jacobson; Neelam Dhiman; Robert A Vierkant; V Shane Pankratz; Gregory A Poland Journal: Pediatrics Date: 2008-05 Impact factor: 7.124
Authors: David M Reif; Brett A McKinney; Alison A Motsinger; Stephen J Chanock; Kathryn M Edwards; Michael T Rock; Jason H Moore; James E Crowe Journal: J Infect Dis Date: 2008-07-01 Impact factor: 5.226
Authors: Richard B Kennedy; Inna G Ovsyannikova; V Shane Pankratz; Robert A Vierkant; Robert M Jacobson; Margaret A K Ryan; Gregory A Poland Journal: Vaccine Date: 2009-02-05 Impact factor: 3.641
Authors: Jenna E Ryan; Neelam Dhiman; Inna G Ovsyannikova; Robert A Vierkant; V Shane Pankratz; Gregory A Poland Journal: J Immunol Methods Date: 2008-11-25 Impact factor: 2.303
Authors: Richard B Kennedy; Inna G Ovsyannikova; V Shane Pankratz; Iana H Haralambieva; Robert A Vierkant; Robert M Jacobson; Gregory A Poland Journal: Hum Genet Date: 2012-06-03 Impact factor: 4.132
Authors: Iana H Haralambieva; Inna G Ovsyannikova; Richard B Kennedy; Beth R Larrabee; V Shane Pankratz; Gregory A Poland Journal: Hum Immunol Date: 2013-06-24 Impact factor: 2.850
Authors: Inna G Ovsyannikova; V Shane Pankratz; Robert A Vierkant; Robert M Jacobson; Gregory A Poland Journal: Vaccine Date: 2012-01-25 Impact factor: 3.641
Authors: Wenan Chen; Beth R Larrabee; Inna G Ovsyannikova; Richard B Kennedy; Iana H Haralambieva; Gregory A Poland; Daniel J Schaid Journal: Genetics Date: 2015-05-06 Impact factor: 4.562
Authors: Inna G Ovsyannikova; V Shane Pankratz; Hannah M Salk; Richard B Kennedy; Gregory A Poland Journal: Hum Genet Date: 2014-06-01 Impact factor: 4.132
Authors: Nathaniel D Lambert; V Shane Pankratz; Beth R Larrabee; Adaeze Ogee-Nwankwo; Min-hsin Chen; Joseph P Icenogle; Gregory A Poland Journal: Clin Vaccine Immunol Date: 2014-01-03
Authors: Richard B Kennedy; Inna G Ovsyannikova; Iana H Haralambieva; Nathaniel D Lambert; V Shane Pankratz; Gregory A Poland Journal: Hum Genet Date: 2014-08-07 Impact factor: 4.132
Authors: Inna G Ovsyannikova; Iana H Haralambieva; Richard B Kennedy; V Shane Pankratz; Robert A Vierkant; Robert M Jacobson; Gregory A Poland Journal: Gene Date: 2012-08-23 Impact factor: 3.688